283 related articles for article (PubMed ID: 35392870)
1. Clustering of lung diseases in the family of interstitial lung disease patients.
Terwiel M; Grutters JC; van Moorsel CHM
BMC Pulm Med; 2022 Apr; 22(1):134. PubMed ID: 35392870
[TBL] [Abstract][Full Text] [Related]
2. Family History of Pulmonary Fibrosis Predicts Worse Survival in Patients With Interstitial Lung Disease.
Cutting CC; Bowman WS; Dao N; Pugashetti JV; Garcia CK; Oldham JM; Newton CA
Chest; 2021 May; 159(5):1913-1921. PubMed ID: 33484728
[TBL] [Abstract][Full Text] [Related]
3. Smoking-related emphysema is associated with idiopathic pulmonary fibrosis and rheumatoid lung.
Antoniou KM; Walsh SL; Hansell DM; Rubens MR; Marten K; Tennant R; Hansel T; Desai SR; Siafakas NM; du Bois RM; Wells AU
Respirology; 2013 Nov; 18(8):1191-6. PubMed ID: 23819865
[TBL] [Abstract][Full Text] [Related]
4. Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis.
Fisher JH; Kolb M; Algamdi M; Morisset J; Johannson KA; Shapera S; Wilcox P; To T; Sadatsafavi M; Manganas H; Khalil N; Hambly N; Halayko AJ; Gershon AS; Fell CD; Cox G; Ryerson CJ
BMC Pulm Med; 2019 Nov; 19(1):223. PubMed ID: 31771541
[TBL] [Abstract][Full Text] [Related]
5. Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA.
Olson AL; Maher TM; Acciai V; Mounir B; Quaresma M; Zouad-Lejour L; Wells CD; De Loureiro L
Adv Ther; 2020 Jul; 37(7):3292-3298. PubMed ID: 32451950
[TBL] [Abstract][Full Text] [Related]
6. Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis.
Hunninghake GM; Quesada-Arias LD; Carmichael NE; Martinez Manzano JM; Poli De Frías S; Baumgartner MA; DiGianni L; Gampala-Sagar SN; Leone DA; Gulati S; El-Chemaly S; Goldberg HJ; Putman RK; Hatabu H; Raby BA; Rosas IO
Am J Respir Crit Care Med; 2020 May; 201(10):1240-1248. PubMed ID: 32011908
[No Abstract] [Full Text] [Related]
7. A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease.
Wong AW; Lee TY; Johannson KA; Assayag D; Morisset J; Fell CD; Fisher JH; Shapera S; Gershon AS; Cox G; Halayko AJ; Hambly N; Manganas H; Sadatsafavi M; Wilcox PG; To T; Marcoux V; Khalil N; Kolb M; Ryerson CJ
Respir Res; 2020 Dec; 21(1):322. PubMed ID: 33287805
[TBL] [Abstract][Full Text] [Related]
8. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
Wells AU; Flaherty KR; Brown KK; Inoue Y; Devaraj A; Richeldi L; Moua T; Crestani B; Wuyts WA; Stowasser S; Quaresma M; Goeldner RG; Schlenker-Herceg R; Kolb M;
Lancet Respir Med; 2020 May; 8(5):453-460. PubMed ID: 32145830
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and Incidence of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype in the United States Estimated in a Large Claims Database Analysis.
Olson AL; Patnaik P; Hartmann N; Bohn RL; Garry EM; Wallace L
Adv Ther; 2021 Jul; 38(7):4100-4114. PubMed ID: 34156606
[TBL] [Abstract][Full Text] [Related]
10. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
Hyldgaard C
Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and prognosis of unclassifiable interstitial lung disease.
Ryerson CJ; Urbania TH; Richeldi L; Mooney JJ; Lee JS; Jones KD; Elicker BM; Koth LL; King TE; Wolters PJ; Collard HR
Eur Respir J; 2013 Sep; 42(3):750-7. PubMed ID: 23222877
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and outcomes of patients hospitalized with interstitial lung diseases in Spain, 2014 to 2015.
Pedraza-Serrano F; Jiménez-García R; López-de-Andrés A; Hernández-Barrera V; Sánchez-Muñoz G; Puente-Maestu L; de-Miguel-Díez J
Medicine (Baltimore); 2019 May; 98(21):e15779. PubMed ID: 31124970
[TBL] [Abstract][Full Text] [Related]
13. Interstitial lung abnormalities and interstitial lung diseases associated with cigarette smoking in a rural cohort undergoing surgical resection.
Sangani RG; Deepak V; Ghio AJ; Forte MJ; Zulfikar R; Patel Z; King A; Alshaikhnassir E; Abbas G; Vos J
BMC Pulm Med; 2022 Apr; 22(1):172. PubMed ID: 35488260
[TBL] [Abstract][Full Text] [Related]
14. Nintedanib: A Review in Fibrotic Interstitial Lung Diseases.
Lamb YN
Drugs; 2021 Apr; 81(5):575-586. PubMed ID: 33765296
[TBL] [Abstract][Full Text] [Related]
15. Health care costs and utilization of progressive fibrosing lung disease by underlying interstitial lung disease type.
Nili M; Steffens A; Anderson A; Brekke L; Grace Johnson M; Veeranki P; Olson AL
J Manag Care Spec Pharm; 2024 Feb; 30(2):163-174. PubMed ID: 38308627
[TBL] [Abstract][Full Text] [Related]
16. Tobacco smoking is associated with combined pulmonary fibrosis and emphysema and worse outcomes in interstitial lung disease.
Douglas D; Keating L; Strykowski R; Lee CT; Garcia N; Selvan K; Kaushik N; Bauer Ventura I; Jablonski R; Vij R; Chung JH; Bellam S; Strek ME; Adegunsoye A
Am J Physiol Lung Cell Mol Physiol; 2023 Aug; 325(2):L233-L243. PubMed ID: 37366539
[TBL] [Abstract][Full Text] [Related]
17. Impact of Gender on the Characteristics of Patients with Idiopathic Pulmonary Fibrosis Included in the RaDiCo-ILD Cohort.
Cottin V; Gueguen S; Jouneau S; Nunes H; Crestani B; Bonniaud P; Wémeau-Stervinou L; Reynaud-Gaubert M; Israël-Biet D; Cadranel J; Marchand-Adam S; Quétant S; Hirschi S; Montani D; Gamez AS; Chevereau M; Dufaure-Garé I; Amselem S; Clement A;
Respiration; 2022; 101(1):34-45. PubMed ID: 34515219
[TBL] [Abstract][Full Text] [Related]
18. Advances with pharmacotherapy for the treatment of interstitial lung disease.
Comes A; Sgalla G; Perrotta A; Richeldi L
Expert Opin Pharmacother; 2022 Mar; 23(4):483-495. PubMed ID: 34907821
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of lung cancer among patients with idiopathic pulmonary fibrosis and interstitial lung disease - analysis of institutional and population data.
Yoon JH; Nouraie M; Chen X; Zou RH; Sellares J; Veraldi KL; Chiarchiaro J; Lindell K; Wilson DO; Kaminski N; Burns T; Trejo Bittar H; Yousem S; Gibson K; Kass DJ
Respir Res; 2018 Oct; 19(1):195. PubMed ID: 30285867
[TBL] [Abstract][Full Text] [Related]
20. Likelihood of pulmonary hypertension in patients with idiopathic pulmonary fibrosis and emphysema.
Jacob J; Bartholmai BJ; Rajagopalan S; Karwoski R; Nair A; Walsh SLF; Barnett J; Cross G; Judge EP; Kokosi M; Renzoni E; Maher TM; Wells AU
Respirology; 2018 Jun; 23(6):593-599. PubMed ID: 29237236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
